Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)
Bausch Health Companies (BHC) reported Amortization - Intangibles of $241.0 million for Q1 2026, down 5.86% on a YoY basis from $256.0 million in Q1 2025, and up 2.12% sequentially from $236.0 million in Q4 2025.
Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Amortization - Intangibles data on file, last reported at $241.0 million in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles fell 5.86% year-over-year to $241.0 million; the trailing twelve-month figure through Mar 2026 stood at $986.0 million (down 6.89% YoY), and the FY2025 full-year result was $1.0 billion, down 7.06% from the prior year.
- Amortization - Intangibles grew to $241.0 million in Q1 2026, from $236.0 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $313.0 million in Q4 2022 to a low of $236.0 million in Q4 2025.
- A 5-year average of $271.2 million and a median of $270.0 million in 2024 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles decreased 16.11% in 2022 and rose 8.3% in 2024, its largest moves.
- Tracing BHC's Amortization - Intangibles over 5 years: stood at $313.0 million in 2022, then decreased by 9.9% to $282.0 million in 2023, then decreased by 8.16% to $259.0 million in 2024, then decreased by 8.88% to $236.0 million in 2025, then increased by 2.12% to $241.0 million in 2026.
- Business Quant data shows BHC's Amortization - Intangibles at $241.0 million in Q1 2026, $236.0 million in Q4 2025, and $253.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.00 Mn |
| Dec 31, 2025 | 236.00 Mn |
| Sep 30, 2025 | 253.00 Mn |
| Jun 30, 2025 | 256.00 Mn |
| Mar 31, 2025 | 256.00 Mn |
| Dec 31, 2024 | 259.00 Mn |
| Sep 30, 2024 | 274.00 Mn |
| Jun 30, 2024 | 270.00 Mn |
| Mar 31, 2024 | 274.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 253.00 Mn |
| Jun 30, 2023 | 269.00 Mn |
| Mar 31, 2023 | 273.00 Mn |
| Dec 31, 2022 | 313.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 302.00 Mn |
| Mar 31, 2022 | 310.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 338.00 Mn |
| Jun 30, 2021 | 360.00 Mn |